Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,002,400 | 3,657,100 | 3,595,300 | 2,365,100 | 1,699,000 |
| Marketable Securities | 49,000 | 24,200 | 35,000 | 22,800 | 78,400 |
| Receivables | 6,658,600 | 6,929,000 | 5,844,800 | 5,775,600 | 6,352,500 |
| Inventories | 3,660,800 | 3,980,300 | 3,555,400 | 3,313,900 | 3,102,400 |
| TOTAL | $16,604,500 | $17,462,100 | $16,239,900 | $14,581,900 | $13,994,200 |
| Non-Current Assets | |||||
| PPE Net | 8,630,100 | 8,681,900 | 8,281,100 | 7,981,100 | 7,897,900 |
| Investments And Advances | 3,232,400 | 2,966,800 | 2,476,200 | 2,406,400 | 2,148,700 |
| Intangibles | 8,087,800 | 7,450,000 | 7,588,600 | 7,712,500 | 7,766,700 |
| Other Non-Current Assets | 10,283,500 | 10,072,300 | 9,360,200 | 9,285,100 | 9,295,300 |
| TOTAL | $30,233,800 | $29,171,000 | $27,706,100 | $27,385,100 | $27,108,600 |
| Total Assets | $46,838,300 | $46,633,100 | $43,946,000 | $41,967,000 | $41,102,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,900 | 8,700 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,639,600 | 1,606,700 | 1,430,100 | 1,247,200 | 1,207,700 |
| Other current liabilities | 9,278,100 | 9,600,500 | 8,785,800 | 8,016,700 | 7,487,100 |
| TOTAL | $11,714,200 | $12,481,600 | $11,976,900 | $11,988,500 | $12,610,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,199,600 | 16,586,600 | 16,334,600 | 15,064,400 | 13,982,300 |
| Other Non-Current Liabilities | 9,624,600 | 9,639,800 | 8,530,800 | 8,602,900 | 9,126,900 |
| TOTAL | $28,024,800 | $28,326,300 | $26,973,100 | $25,706,500 | $25,295,400 |
| Total Liabilities | $39,739,000 | $40,807,900 | $38,950,000 | $37,695,000 | $37,905,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 959,026 | 958,426 | 956,582 | 956,470 | 956,450 |
| Common Shares | 599,700 | 598,200 | 598,100 | 598,100 | 598,100 |
| Retained earnings | 9,181,300 | 7,830,200 | 7,154,000 | 6,617,200 | 5,879,400 |
| Other shareholders' equity | -9,207,900 | -9,325,700 | -9,398,900 | -9,516,700 | -9,780,400 |
| TOTAL | $7,099,300 | $5,825,200 | $4,996,000 | $4,272,000 | $3,197,200 |
| Total Liabilities And Equity | $46,838,300 | $46,633,100 | $43,946,000 | $41,967,000 | $41,102,800 |